Related Experiment Videos
Dendritic cells in rheumatoid arthritis.
1University of Michigan, 1500 W. Medical Center Drive, Ann Arbor, MI 48109-0358, USA.
Frontiers in Bioscience : a Journal and Virtual Library
|December 1, 2004
Summary
Dendritic cells (DCs) in rheumatoid arthritis (RA) synovium present antigens and may drive disease. Modifying DCs, like with IL-4 gene therapy, shows promise for treating autoimmune arthritis in mice.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Dendritic cells (DCs) are potent antigen-presenting cells crucial for immune responses.
- DCs reside in peripheral tissues and migrate to lymph nodes upon activation.
- In rheumatoid arthritis (RA), DCs are found in joints and express key molecules for T cell interaction.
Purpose of the Study:
- To investigate the role of dendritic cells in the pathogenesis of rheumatoid arthritis.
- To explore dendritic cells as potential therapeutic targets or delivery vehicles for autoimmune diseases.
Main Methods:
- Characterization of dendritic cells in rheumatoid arthritis synovium and joint fluid.
- Analysis of DC surface molecule expression (MHC II, CD40, CD80, CD86, DC-SIGN, CCR7).
- Assessment of DC capacity to polarize T cells (Th1/Th2) based on cytokine environment.
Main Results:
- DCs in RA synovium express markers associated with antigen presentation and T cell co-stimulation.
- The RA cytokine milieu supports DC differentiation and function, potentially leading to autoantigen presentation.
- Genetically modified DCs expressing IL-4 successfully treated collagen-induced arthritis in a mouse model.
Conclusions:
- Dendritic cells play a significant role in rheumatoid arthritis pathogenesis.
- DCs are viable targets for RA treatment strategies.
- Gene-modified DCs offer a potential therapeutic approach for autoimmune diseases like RA.